ArticleNanomaterials (Basel, Switzerland)2020
An Emerging Visible-Light Organic-Inorganic Hybrid Perovskite for Photocatalytic Applications.
Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Composite ZIF-8 with CsMolecules (Basel, Switzerland) · 2025Article
- Complex Catalytic Materials Based on the Perovskite-Type Structure for Energy and Environmental Applications.Materials (Basel, Switzerland) · 2020Review
- Advances in Heterocatalysis by Nanomaterials.Nanomaterials (Basel, Switzerland) · 2020Article
- Effects of Annealing on Characteristics of CuNanomaterials (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The development of visible-light active photocatalysts is a current challenge especially energy and environmental-related fields. Herein, methylammonium lead iodide perovskite (MAIPb) was chosen as the novel semiconductor material for its ability of absorbing visible-light. An easily reproducible and efficient method was employed to synthesize the as-mentioned material. The sample was characterized by various techniques and has been used as visible-light photocatalyst for degradation of two model pollutants: rhodamine B (RhB) and methylene-blue (MB). The photo-degradation of RhB was found to achieve about 65% after 180 min of treatment. Moreover, the efficiency was enhanced to 100% by assisting the process with a small amount of H
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.